Library — CHDR

Search

Filter

The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol.

Zoethout RW, Iannone R, Bloem BR, Palcza J, Murphy G, Chodakewitz J, Buntinx A, Gottesdiener K, Marsilio S, Rosen L, van Dyck K, Louis ED, Cohen AF, Schoemaker RC, Tokita S, Sato N, Koblan KS, Hargreaves RH, Renger J, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2012 Jan; 26(2):292-302

View publication
Involvement of the endocannabinoid system in reward processing in the human brain.

van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF

Psychopharmacology, 2012 Jan; 219(4):981-90

View publication
The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol.

de Haas SL, Zoethout RW, Van Dyck K, De Smet M, Rosen LB, Murphy MG, Gottesdiener KM, Schoemaker RC, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2012 Jan; 26(2):282-91

View publication
Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state.

te Beek ET, Zoethout RW, Bani MS, Andorn A, Iavarone L, Klaassen ES, Fina P, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2012 Jan; 26(2):303-14

View publication
Tolvaptan.

Dubois EA, Rissmann R, Cohen AF

British journal of clinical pharmacology, 2011 Dec; 73(1):9-11

View publication
Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.

Moerland M, Kemme M, Dijkmans A, Bergougnan L, Burggraaf J

Journal of cardiovascular pharmacology, 2011 Nov; 58(6):575-80

View publication
Introduction to haemostasis from a pharmacodynamic perspective.

Kluft C, Burggraaf J

British journal of clinical pharmacology, 2011 Sep; 72(4):538-46

View publication
The perception and pharmacokinetics of a 20-mg dose of escitalopram orodispersible tablets in a relative bioavailability study in healthy men.

Nilausen DØ, Zuiker RG, van Gerven J

Clinical therapeutics, 2011 Sep; 33(10):1492-502

View publication
Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content.

Geerts BF, van Dongen MG, Flameling B, Moerland MM, de Kam ML, Cohen AF, Romijn JA, Gerhardt CC, Kloek J, Burggraaf J

Journal of dietary supplements, 2011 Aug; 8(3):280-92

View publication

«
1
2
...
59
60
61
62
63
64
65
...
98
99
»